Anebulo Pharmaceuticals (ANEB) Earnings Date, Estimates & Call Transcripts

$2.79
0.00 (0.00%)
(As of 04/25/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Feb. 13)
-$0.11
Consensus EPS
(Feb. 13)
-$0.11
Skip Charts & View Estimated and Actual Earnings Data

ANEB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANEB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anebulo Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.11)($0.11)($0.11)
Q2 20241($0.11)($0.11)($0.11)
Q3 20241($0.11)($0.11)($0.11)
Q4 20241($0.14)($0.14)($0.14)
FY 20244($0.47)($0.47)($0.47)

ANEB Earnings Date and Information

Anebulo Pharmaceuticals last announced its earnings results on February 13th, 2024. The reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). Anebulo Pharmaceuticals has generated ($0.42) earnings per share over the last year (($0.42) diluted earnings per share). Earnings for Anebulo Pharmaceuticals are expected to decrease in the coming year, from ($0.47) to ($0.52) per share. Anebulo Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Anebulo Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
2/13/2024Q2 2024($0.11)($0.11)-($0.11)--
11/14/2023Q1 2024($0.11)($0.10)+$0.01($0.10)--
9/20/2023Q4 2023($0.10)($0.10)-($0.10)--
5/11/2023Q3 2023-($0.11)($0.11)($0.11)--
2/10/2023Q2 2023-($0.15)($0.15)($0.15)--
11/10/2022Q1 2023-($0.11)($0.11)($0.11)--
9/9/2022Q4 2022-($0.10)($0.10)($0.10)--
5/11/2022Q3 2022-($0.08)($0.08)($0.08)--
2/11/2022Q2 2022-($0.05)($0.05)($0.05)--    
11/12/2021Q3 2021($0.11)($0.07)+$0.04($0.07)--
9/21/2021Q4($0.03)($1.59)($1.56)$1.33--
6/20/2021Q3 2021($0.04)($0.69)($0.65)($0.69)--

Anebulo Pharmaceuticals Earnings - Frequently Asked Questions

When is Anebulo Pharmaceuticals's earnings date?

Anebulo Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on ANEB's earnings history.

Did Anebulo Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Anebulo Pharmaceuticals (NASDAQ:ANEB) reported ($0.11) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.11). Learn more on analysts' earnings estimate vs. ANEB's actual earnings.

How much profit does Anebulo Pharmaceuticals generate each year?

Anebulo Pharmaceuticals (NASDAQ:ANEB) has a recorded net income of -$11.73 million. ANEB has generated -$0.42 earnings per share over the last four quarters.

What is Anebulo Pharmaceuticals's EPS forecast for next year?

Anebulo Pharmaceuticals's earnings are expected to decrease from ($0.47) per share to ($0.52) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ANEB) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners